Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Notes Payables (2020 - 2023)

Historic Notes Payables for Firefly Neuroscience (AIFF) over the last 3 years, with Q3 2023 value amounting to $94071.0.

  • Firefly Neuroscience's Notes Payables changed N/A to $94071.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $94071.0, marking a year-over-year change of. This contributed to the annual value of $450000.0 for FY2020, which is N/A changed from last year.
  • Per Firefly Neuroscience's latest filing, its Notes Payables stood at $94071.0 for Q3 2023.
  • Firefly Neuroscience's 5-year Notes Payables high stood at $1.5 million for Q2 2021, and its period low was $37157.0 during Q3 2020.
  • Over the past 3 years, Firefly Neuroscience's median Notes Payables value was $186115.0 (recorded in 2023), while the average stood at $450704.1.
  • The largest annual percentage gain for Firefly Neuroscience's Notes Payables in the last 5 years was 312456.33% (2021), contrasted with its biggest fall of 91788.37% (2021).
  • Over the past 3 years, Firefly Neuroscience's Notes Payables (Quarter) stood at $450000.0 in 2020, then soared by 166.26% to $1.2 million in 2021, then crashed by 92.15% to $94071.0 in 2023.
  • Its last three reported values are $94071.0 in Q3 2023, $186115.0 for Q2 2023, and $276173.0 during Q1 2023.